Dataset
LS513 Combination MTT Excel Files for SynergyFinder+ (Figure 5) 开放存取 Deposited
LS513 cells were treated with a combination of varying concentrations of MRTX1133 with varying concentrations of either afatinib, sapitinib, or pelitinib for 72 hours. Absorbances were normalized to DMSO control for % viability. The attached files were compiled in data format from n=2 data sets (6 data points total for each combination) and uploaded to SynergyFinder+ with % viability chosen as response.
- 副标题
- Synergy Graphs
- 创建者
- 证书
- 学科
- 地理主题
- 提交
- 学
- 部门
- 创建日期
- 出版者
- 语言
Digital Object Identifier (DOI)
识别码: doi:10.7945/93c3-tn29
链接: https://doi.org/10.7945/93c3-tn29
这个DOI链接是其他人引用您工作的最佳方式。
单件
| 缩略图 | 标题 | 上传日期 | 公开度 | 行动 |
|---|---|---|---|---|
|
|
Synergyfinder_-_Combination_MRTX1133_Afatinib_MTT_LS513_Fig_5.xlsx | 2025-03-07 | 开放存取 |
|
|
|
Synergyfinder_-_Combination_MRTX1133_Pelitinib_MTT_LS513_Fig_5.xlsx | 2025-03-07 | 开放存取 |
|
|
|
Synergyfinder_-_Combination_MRTX1133_Sapitinib_MTT_LS513_Fig_5.xlsx | 2025-03-07 | 开放存取 |
|
永久链接到此页面: https://scholar.uc.edu/show/hq37vq09c